Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2. (Q39586490)
Jump to navigation
Jump to search
scientific article published on 18 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2. |
scientific article published on 18 July 2016 |
Statements
1 reference
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2. (English)
1 reference
Lucio Crinò
1 reference
Myung-Ju Ahn
1 reference
Filippo De Marinis
1 reference
Harry J M Groen
1 reference
Heather Wakelee
1 reference
Toyoaki Hida
1 reference
David Spigel
1 reference
Makoto Nishio
1 reference
Giorgio Scagliotti
1 reference
Fabrice Branle
1 reference
Chetachi Emeremni
1 reference
Massimiliano Quadrigli
1 reference
Jie Zhang
1 reference
Alice T Shaw
1 reference
18 July 2016
1 reference
1 reference
34
1 reference
24
1 reference
2866-2873
1 reference
Identifiers
1 reference
1 reference